CoChat

The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies

Open access

The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index; 19 of the 79 sources its claims cite were checked for support.

Abstract

The fine line between human health and disease can be driven by the interplay between host and microbial factors. This “metagenome” regulates cancer initiation, progression, and response to therapies. Besides the capacity of distinct microbial species to modulate the pharmacodynamics of chemotherapeutic drugs, symbiosis between epithelial barriers and their microbial ecosystems has a major impact on the local and distant immune system, markedly influencing clinical outcome in cancer patients. Efficacy of cancer immunotherapy with immune checkpoint antibodies can be diminished with administration of antibiotics, and superior efficacy is observed with the presence of specific gut microbes. Future strategies of precision medicine will likely rely on novel diagnostic and therapeutic tools with which to identify and correct defects in the microbiome that compromise therapeutic efficacy.

Overview

Integrity signals

Registry

Crossref · 10.1126/science.aar6918

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

13 Valid · 0 Not valid · 43 Not checked · 11 Own results and interpretations

33 more claims · 2 with their cited sources checked

Create a free account to see all 67 claims and to verify the 60 references still open.

See all claims — free account
  • Probably not a substantial claim. 4
  • It may state two separate claims as one. 26

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

1 retracted

Show all 74 references

Cited by

Items 201–300 of 793

Metadata

Authors
Zitvogel, L., Ma, Y., Raoult, D., Kroemer, G., & Gajewski, T. F.
Affiliations
  • Université Paris-Sud (FR)
  • Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
  • Centre National de la Recherche Scientifique (FR)
  • Sorbonne Paris Cité (FR)
  • University of Chicago (US)
Corresponding author
  • Zitvogel, Laurence
  • Gajewski, Thomas F.
Venue
Science
Published
2018-03-23
Volume
359
Issue
6382
Pages
1366-1370
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W2791926234
Cited by
777
References
74
Citations by year
2026: 84 · 2025: 85 · 2024: 74 · 2023: 96 · 2022: 84 · 2021: 130 · 2020: 105 · 2019: 81 · 2018: 37
FWCI
8.71
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Science (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
Funders
  • Melanoma Research Alliance (CA210098)
  • University of Chicago (T32 CA009594)
  • Association pour la Recherche sur le Cancer
  • Seerave Foundation
  • Jounce Therapeutics
  • Incyte
  • E-Rare
  • European Commission
  • Agence Nationale de la Recherche (ANR-10-LABX-0015)
  • Fondation Leducq
  • National Natural Science Foundation of China (81671630, CAMS-I2M, 2017YFA0506200, 81722037)
  • Fondation pour la Recherche Médicale
  • Government of Jiangsu Province
  • Ligue Contre le Cancer
  • Natural Science Foundation of Jiangsu Province (BK20170006, BK20160379)
  • Institut Universitaire de France
  • Chinese Academy of Medical Sciences (2016‐I2M‐1‐005, (CAMS-I2M), 2017RC31008, 2017NL31004, 2016ZX310194)
  • Institut National Du Cancer
  • Institut Gustave-Roussy
  • Recruitment Program of Global Experts
  • Genentech
  • University of Chicago Medicine
  • National Key Research and Development Program of China (2017YFA0506200)
  • Labex Immuno-Oncology
  • Comprehensive Cancer Center, University of Chicago Medical Center (T32 CA009594)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
Keywords
gut microbiota, cancer immunotherapy, immune checkpoint inhibitors, host-microbe interactions, precision medicine, microbiome-based diagnostics, microbiota-based therapy, cancer immunotherapy resistance
MeSH terms
Gastrointestinal Microbiome, Humans, Immune System, Immunotherapy, Neoplasms, Treatment Outcome, Metagenome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.